NCT01481597View on ClinicalTrials.gov

Deuteporfin Tolerance and Pharmacokinetics in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

April 30, 2012

Study Completion Date

April 30, 2012

Conditions
Healthy
Interventions
DRUG

deuteporfin

deuteporfin 1 mg/kg IV as a single dose

DRUG

deuteporfin

deuteporfin 2.5 mg/kg IV as a single dose

DRUG

deuteporfin

deuteporfin 5 mg/kg IV as a single dose

DRUG

deuteporfin

deuteporfin 7.5 mg/kg IV as a single dose

DRUG

placebo

Placebo for 2.5 mg/kg, 5 mg/kg and 7.5mg/kg of deuteporfin (single dose)

Trial Locations (1)

410008

Xiangya Hospital of Central-South University, Changsha

All Listed Sponsors
lead

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.

INDUSTRY

NCT01481597 - Deuteporfin Tolerance and Pharmacokinetics in Healthy Volunteers | Biotech Hunter | Biotech Hunter